Similarly, inhibition of Drp1 hyperactivation by P110, a selective Drp1 peptide inhibitor (Qi et al., 2013), reduced the number of fragmented mitochondria and attenuated AD pathology and behavioral deficits in 5XFAD AD mice (Joshi et al., 2018). The gene discussed is DNM1L; the disease is Alzheimer disease.